Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 5Other solid neoplasm 3Other hematologic neoplasm 3Genitourinary 3Gastrointestinal 3Thoracic 2Dermatologic 2Breast 2Sarcoma 1Myeloid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 3

Interventions

Cisplatin 28Irinotecan 18Gemcitabine 18Paclitaxel 14alvocidib 13Fluorouracil 11Oxaliplatin 10Cyclophosphamide 10Carboplatin 10Leucovorin 8Bortezomib 8Biopsy 8Taxes 7Radiotherapy 7Pemetrexed 7Magnetic Resonance Spectroscopy 7Doxorubicin 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Specimen Handling 6tanespimycin 5Vorinostat 5LMB-100 5Early Intervention, Educational 5Bevacizumab 5temsirolimus 4sargramostim 4Sorafenib 4Sirolimus 4Platinum 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × 7-hydroxystaurosporine × Other solid neoplasm × Clear all
NCT00042861 2015-04-30

UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00012194 2013-07-09

7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors

National Cancer Institute (NCI)

Phase 1 Terminated
30 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00036777 2013-07-01

UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡